Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Oncotelic Therapeutics Inc
OTLC
Healthcare
Biotechnology
Oncotelic Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing drugs for the treatment of orphan oncology indications, developing antisense and small-molecule injectable drugs for the treatment of cancer. The Company has three primary drugs and AI technology programs: AL-101 - Intranasal drug and delivery system for intra-nasal Apomorphine for the treatment of...
Parkinson’s Disease (PD), erectile dysfunction (ED) and female sexual dysfunction (FSD); CA4P- a vascular disrupting agent (VDA) - in combination with Ipilimumab for the treatment of solid tumors with focus on melanoma in adult and pediatric melanoma; Oxi4503- a second generation VDA - for the treatment of liquid tumors with focus on childhood leukemia; OT-101 - an antisense against TGF-b2-for the treatment of various cancers and for the treatment of various viruses, and Artemisinin-a natural derivative from an Asian herb Artemisia Annua.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (OTCQB:OTLC)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
Next
(0)
•••
ckruel
X
Post by
ckruel
on Sep 24, 2024 1:15pm
Otlc price target
Analyst placed a $4 USD target on otlc.... https://www.barrons.com/market-data/stocks/otlc Picked up 50k just in case.
(0)
•••
DepartedSe7en
X
Post by
DepartedSe7en
on Apr 05, 2023 8:41pm
Oncotelic Announces Release of Pet2DAO Tokens (PDAO)
Oncotelic Announces Release of Pet2DAO Tokens (PDAO) - Oncotelic Therapeutics (OTC:OTLC) - Benzinga
(0)
•••
DepartedSe7en
X
Post by
DepartedSe7en
on Oct 17, 2022 6:44pm
Oncotelic Awarded BARDA Funding for Development of OT-101
Oncotelic Awarded BARDA Funding for Development of OT-101 for long COVID: https://www.yahoo.com/now/oncotelic-awarded-barda-funding-development-110000810.html
(0)
•••
DepartedSe7en
X
Post by
DepartedSe7en
on Jun 15, 2022 5:03pm
Oncotelic Announces Pipeline Presentation and IPO Update of
Oncotelic Announces Pipeline Presentation and IPO Update of Sapu Therapeutics at the 2022 BIO International Convention: https://finance.yahoo.com/news/oncotelic-announces-pipeline-presentation
...more
(28)
•••
satchmo6
X
Comment by
satchmo6
on May 23, 2022 4:28pm
RE:ONCOTELIC PROVIDES Q1 2022 FINANCIAL RESULTS COMPARED TO Q1
finally a US company posting on a day of trading , not like 5 pages of CDN posts for tomorrow,
(0)
•••
DepartedSe7en
X
Post by
DepartedSe7en
on May 23, 2022 1:24pm
ONCOTELIC PROVIDES Q1 2022 FINANCIAL RESULTS COMPARED TO Q1
ONCOTELIC PROVIDES Q1 2022 FINANCIAL RESULTS COMPARED TO Q1 (globenewswire.com)
(0)
•••
DepartedSe7en
X
Post by
DepartedSe7en
on May 04, 2022 12:57pm
Oncotelic Appoints Fatih Uckun, M.D., Ph.D., as CMO
Oncotelic Appoints Fatih Uckun, M.D., Ph.D., as Chief Medical Officer: https://oncotelic.irpass.com/Oncotelic-Appoints-Fatih-Uckun--M-D---Ph-D---as-Chief-Medical-Officer-5-3-2022
...more
(0)
•••
DepartedSe7en
X
Post by
DepartedSe7en
on May 04, 2022 12:57pm
Oncotelic Appoints Seymour Fein M.D. as CRO
Oncotelic Appoints Seymour Fein M.D. as Chief Regulatory Officer: https://oncotelic.irpass.com/Oncotelic-Appoints-Seymour-Fein-M-D--as-Chief-Regulatory-Officer-5-4-2022
(0)
•••
DepartedSe7en
X
Post by
DepartedSe7en
on Apr 04, 2022 4:17pm
Oncotelic; Announcing Successful Joint Venture and Diving in
Oncotelic; Announcing Successful Joint Venture and Diving into Benefits for Shareholders: https://www.youtube.com/watch?v=sr3qbea_mCM
(0)
•••
DepartedSe7en
X
Post by
DepartedSe7en
on Apr 01, 2022 2:18pm
Oncotelic presentation at MedInvest Pharmaceutical & Biotech
Oncotelic presentation at MedInvest Pharmaceutical & Biotechnology Investor Conference: https://www.youtube.com/watch?v=Ys4V5qZt4sA
(0)
•••
DepartedSe7en
X
Post by
DepartedSe7en
on Mar 21, 2022 3:48pm
Oncotelic JV Financing
Oncotelic JV Financing: https://www.youtube.com/watch?v=k0Zj59shmw0
(0)
•••
DepartedSe7en
X
Post by
DepartedSe7en
on Mar 15, 2022 7:16pm
Oncotelic; Looking at Industry Comparison for the Company
Oncotelic; Looking at Industry Comparison for the Company: https://www.youtube.com/watch?v=Dnkmg0k7W0U
(0)
•••
DepartedSe7en
X
Post by
DepartedSe7en
on Mar 15, 2022 7:16pm
Oncotelic; Discussing the Company's Development Pipeline
Oncotelic; Discussing the Company's Development Pipeline: https://www.youtube.com/watch?v=FPBbAif6M9I
(0)
•••
DepartedSe7en
X
Post by
DepartedSe7en
on Mar 15, 2022 7:15pm
Oncotelic; Diving into the Company's Outlook for 2022
Oncotelic; Diving into the Company's Outlook for 2022: https://www.youtube.com/watch?v=FPBbAif6M9I
(0)
•••
DepartedSe7en
X
Post by
DepartedSe7en
on Mar 10, 2022 2:15pm
Oncotelic to Present New Studies on its TGF-ß Program at the
Oncotelic to Present New Studies on its TGF- Program at the American Association for Cancer Research (AACR) Annual Meeting 2022: https://apnews.com/press-release/globe-newswire/covid-science
...more
Prev
1
2
3
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >